Copyright Reports & Markets. All rights reserved.

Global Alfuzosin Hydrochloride Sustained Release Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 2.5mg
    • 1.3.3 5mg
    • 1.3.4 10mg
  • 1.4 Market Analysis by Prescription Duration
    • 1.4.1 Overview: Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Prescription Duration: 2021 Versus 2025 Versus 2032
    • 1.4.2 Up to 30 Days
    • 1.4.3 31–90 Days
    • 1.4.4 Above 90 Days
  • 1.5 Market Analysis by Brand Positioning
    • 1.5.1 Overview: Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Brand Positioning: 2021 Versus 2025 Versus 2032
    • 1.5.2 Originator Premium Brand
    • 1.5.3 Regional Branded Generic
    • 1.5.4 Standard Retail Generic
    • 1.5.5 Institutional Tender Generic
  • 1.6 Market Analysis by Application
    • 1.6.1 Overview: Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Hospital
    • 1.6.3 Clinic
    • 1.6.4 Other
  • 1.7 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size & Forecast
    • 1.7.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.7.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity (2021-2032)
    • 1.7.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.1.4 Sanofi Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 ADVANZ Pharma
    • 2.2.1 ADVANZ Pharma Details
    • 2.2.2 ADVANZ Pharma Major Business
    • 2.2.3 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.2.4 ADVANZ Pharma Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 ADVANZ Pharma Recent Developments/Updates
  • 2.3 Apotex Inc.
    • 2.3.1 Apotex Inc. Details
    • 2.3.2 Apotex Inc. Major Business
    • 2.3.3 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.3.4 Apotex Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Apotex Inc. Recent Developments/Updates
  • 2.4 Cipla Limited
    • 2.4.1 Cipla Limited Details
    • 2.4.2 Cipla Limited Major Business
    • 2.4.3 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.4.4 Cipla Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Cipla Limited Recent Developments/Updates
  • 2.5 Sun Pharmaceutical Industries Limited
    • 2.5.1 Sun Pharmaceutical Industries Limited Details
    • 2.5.2 Sun Pharmaceutical Industries Limited Major Business
    • 2.5.3 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.5.4 Sun Pharmaceutical Industries Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Sun Pharmaceutical Industries Limited Recent Developments/Updates
  • 2.6 Unichem Laboratories Limited
    • 2.6.1 Unichem Laboratories Limited Details
    • 2.6.2 Unichem Laboratories Limited Major Business
    • 2.6.3 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.6.4 Unichem Laboratories Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Unichem Laboratories Limited Recent Developments/Updates
  • 2.7 Aurobindo Pharma Limited
    • 2.7.1 Aurobindo Pharma Limited Details
    • 2.7.2 Aurobindo Pharma Limited Major Business
    • 2.7.3 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.7.4 Aurobindo Pharma Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Aurobindo Pharma Limited Recent Developments/Updates
  • 2.8 Wockhardt Limited
    • 2.8.1 Wockhardt Limited Details
    • 2.8.2 Wockhardt Limited Major Business
    • 2.8.3 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.8.4 Wockhardt Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Wockhardt Limited Recent Developments/Updates
  • 2.9 Rising Pharma Holdings, Inc.
    • 2.9.1 Rising Pharma Holdings, Inc. Details
    • 2.9.2 Rising Pharma Holdings, Inc. Major Business
    • 2.9.3 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.9.4 Rising Pharma Holdings, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Rising Pharma Holdings, Inc. Recent Developments/Updates
  • 2.10 Zentiva Group, a.s.
    • 2.10.1 Zentiva Group, a.s. Details
    • 2.10.2 Zentiva Group, a.s. Major Business
    • 2.10.3 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.10.4 Zentiva Group, a.s. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Zentiva Group, a.s. Recent Developments/Updates
  • 2.11 Taj Pharmaceuticals Limited
    • 2.11.1 Taj Pharmaceuticals Limited Details
    • 2.11.2 Taj Pharmaceuticals Limited Major Business
    • 2.11.3 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.11.4 Taj Pharmaceuticals Limited Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Taj Pharmaceuticals Limited Recent Developments/Updates
  • 2.12 Exelan Pharmaceuticals, Inc.
    • 2.12.1 Exelan Pharmaceuticals, Inc. Details
    • 2.12.2 Exelan Pharmaceuticals, Inc. Major Business
    • 2.12.3 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.12.4 Exelan Pharmaceuticals, Inc. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Exelan Pharmaceuticals, Inc. Recent Developments/Updates
  • 2.13 Lunan Better Pharmaceutical Co., Ltd.
    • 2.13.1 Lunan Better Pharmaceutical Co., Ltd. Details
    • 2.13.2 Lunan Better Pharmaceutical Co., Ltd. Major Business
    • 2.13.3 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.13.4 Lunan Better Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Lunan Better Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.14 Anxo Pharmaceutical Co., Ltd.
    • 2.14.1 Anxo Pharmaceutical Co., Ltd. Details
    • 2.14.2 Anxo Pharmaceutical Co., Ltd. Major Business
    • 2.14.3 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Product and Services
    • 2.14.4 Anxo Pharmaceutical Co., Ltd. Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Anxo Pharmaceutical Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Alfuzosin Hydrochloride Sustained Release Tablets by Manufacturer

  • 3.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Alfuzosin Hydrochloride Sustained Release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Alfuzosin Hydrochloride Sustained Release Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Alfuzosin Hydrochloride Sustained Release Tablets Manufacturer Market Share in 2025
  • 3.5 Alfuzosin Hydrochloride Sustained Release Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Alfuzosin Hydrochloride Sustained Release Tablets Market: Region Footprint
    • 3.5.2 Alfuzosin Hydrochloride Sustained Release Tablets Market: Company Product Type Footprint
    • 3.5.3 Alfuzosin Hydrochloride Sustained Release Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region
    • 4.1.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price by Region (2021-2032)
  • 4.2 North America Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021-2032)
  • 4.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021-2032)
  • 4.5 South America Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Alfuzosin Hydrochloride Sustained Release Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
    • 7.3.1 North America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
    • 8.3.1 Europe Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
    • 10.3.1 South America Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Alfuzosin Hydrochloride Sustained Release Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Alfuzosin Hydrochloride Sustained Release Tablets Market Drivers
  • 12.2 Alfuzosin Hydrochloride Sustained Release Tablets Market Restraints
  • 12.3 Alfuzosin Hydrochloride Sustained Release Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Alfuzosin Hydrochloride Sustained Release Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Alfuzosin Hydrochloride Sustained Release Tablets
  • 13.3 Alfuzosin Hydrochloride Sustained Release Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Alfuzosin Hydrochloride Sustained Release Tablets Typical Distributors
  • 14.3 Alfuzosin Hydrochloride Sustained Release Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Alfuzosin Hydrochloride Sustained Release Tablets market size was valued at US$ 383 million in 2025 and is forecast to a readjusted size of US$ 511 million by 2032 with a CAGR of 4.2% during review period.
    Alfuzosin Hydrochloride Extended-Release Tablets are finished prescription oral solid-dose products containing alfuzosin hydrochloride as the sole active ingredient and using a documented sustained, extended, prolonged or modified-release mechanism. The market includes nationally approved 5 mg, 10 mg and other sustained-release strengths; originator brands, branded generics and unbranded generics; multilayer, hydrophilic-matrix, hydrophobic-matrix and mixed-matrix tablets; and blister, bottle and institutional packs sold through retail pharmacies, hospital pharmacies, mail-order pharmacies and public-procurement channels. Immediate-release alfuzosin tablets, active pharmaceutical ingredient, fixed-dose combinations, other alpha blockers, pharmacy dispensing margins, diagnostic services, procedures and clinical-trial supply are excluded. In 2025, the product global weighted average selling price of approximately US$0.39 per tablet, global sales volume of approximately 955 million tablets, and an average gross margin of about 52%. Upstream activities mainly include the production of alfuzosin hydrochloride API, sustained-release matrix materials, binders, fillers, lubricants, coating materials, and pharmaceutical packaging materials. Midstream activities include formulation development, granulation, tableting, coating, dissolution testing, stability testing, bioequivalence studies, regulatory filing, packaging, and batch release. Downstream customers mainly include pharmaceutical wholesalers, retail pharmacies, hospital pharmacies, public procurement agencies, hospitals, and clinics.
    Demand is supported by population aging, wider diagnosis of lower urinary tract symptoms and continued use of alpha-blocker therapy for benign prostatic hyperplasia. Once-daily extended-release tablets offer a simpler regimen than immediate-release tablets requiring multiple daily doses.
    Unit-volume growth is expected to remain faster than revenue growth. Generic approvals, hospital tenders and public-procurement programs increase access but also reduce the weighted manufacturer selling price.
    The 10 mg once-daily formulation is the principal commercial form in the United States and many European markets. Some countries retain 5 mg prolonged-release products administered twice daily, creating differences in prescription volume and tablet consumption.
    Modified-release manufacturing presents a higher technical barrier than ordinary immediate-release tablets. Release architecture, food effect, dissolution profiles, stability and bioequivalence must remain consistent during commercial scale-up and post-approval changes.
    Administration requirements affect adherence. Current labels generally require the tablet to be swallowed whole, and many products are taken with food or after the same meal each day. Crushing or chewing may alter the intended release profile.
    Commercial competition comes from tamsulosin, silodosin and other alpha blockers, as well as five-alpha-reductase inhibitors, tadalafil and fixed-dose treatment strategies. These alternatives limit the share that alfuzosin can obtain from growth in the broader benign prostatic hyperplasia population.
    Important commercial and regulatory considerations include postural hypotension, syncope, hepatic impairment, interactions with strong metabolic inhibitors, interval-prolongation caution and disclosure before cataract surgery. These factors influence patient selection, formulary decisions and promotional boundaries.
    Report Scope
    This report is a detailed and comprehensive analysis for global Alfuzosin Hydrochloride Sustained Release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Alfuzosin Hydrochloride Sustained Release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (Million tablets), and average selling prices (US$/tablet), 2021-2032
    Global Alfuzosin Hydrochloride Sustained Release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Million tablets), and average selling prices (US$/tablet), 2021-2032
    Global Alfuzosin Hydrochloride Sustained Release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Million tablets), and average selling prices (US$/tablet), 2021-2032
    Global Alfuzosin Hydrochloride Sustained Release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (Million tablets), and ASP (US$/tablet), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Alfuzosin Hydrochloride Sustained Release Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Alfuzosin Hydrochloride Sustained Release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, ADVANZ Pharma, Apotex Inc., Cipla Limited, Sun Pharmaceutical Industries Limited, Unichem Laboratories Limited, Aurobindo Pharma Limited, Wockhardt Limited, Rising Pharma Holdings, Inc., Zentiva Group, a.s., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Alfuzosin Hydrochloride Sustained Release Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market Segmentation
    Market segment by Type
    2.5mg
    5mg
    10mg
    Market segment by Prescription Duration
    Up to 30 Days
    31–90 Days
    Above 90 Days
    Market segment by Brand Positioning
    Originator Premium Brand
    Regional Branded Generic
    Standard Retail Generic
    Institutional Tender Generic
    Market segment by Application
    Hospital
    Clinic
    Other
    Major players covered
    Sanofi
    ADVANZ Pharma
    Apotex Inc.
    Cipla Limited
    Sun Pharmaceutical Industries Limited
    Unichem Laboratories Limited
    Aurobindo Pharma Limited
    Wockhardt Limited
    Rising Pharma Holdings, Inc.
    Zentiva Group, a.s.
    Taj Pharmaceuticals Limited
    Exelan Pharmaceuticals, Inc.
    Lunan Better Pharmaceutical Co., Ltd.
    Anxo Pharmaceutical Co., Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe Alfuzosin Hydrochloride Sustained Release Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Alfuzosin Hydrochloride Sustained Release Tablets, with price, sales quantity, revenue, and global market share of Alfuzosin Hydrochloride Sustained Release Tablets from 2021 to 2026.
    Chapter 3, the Alfuzosin Hydrochloride Sustained Release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Alfuzosin Hydrochloride Sustained Release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Alfuzosin Hydrochloride Sustained Release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Alfuzosin Hydrochloride Sustained Release Tablets.
    Chapter 14 and 15, to describe Alfuzosin Hydrochloride Sustained Release Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now